Ocular Therapeutix (OCUL) Misses Q1 EPS by 31c

Ocular Therapeutix (NASDAQ: OCUL) reported Q1 EPS of ($0.49), $0.31 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $14.77 million versus the consensus estimate of $15.36 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• BW LPG Limited (BWLP) Reports Q1 EPS of $0.79
• Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak